The company's board of directors approved the acquisition of 30% equity in Tianjin Ruipai Supply Chain Management Co., Ltd. for RMB 65.865 million. This acquisition aims to deepen the company's strategic layout in the pet health sector, strengthen control over core channels, and enhance market competitiveness. The transaction is expected to have no adverse impact on the company's financial status or operating results.
Summary generated by AI · Always verify with source document
Repur Biological Engineering Co., Ltd.
Resolution Announcement of the 5th Extraordinary Meeting of the 6th Board of Directors
The company and all members of the board of directors guarantee the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.